Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova

A B Gilmore, C Radu-Loghin, I Zatushevski, M McKee

Research output: Contribution to journalArticle

  • 23 Citations

Abstract

Moldova, one of the former Soviet republics and Europe's poorest country, has so far resisted pressure to privatise its tobacco industry. This paper examines the policies pursued by the transnational tobacco companies in Moldova in order to inform the ongoing debate about tobacco industry privatisation. We analysed relevant internal industry documents made public through litigation. The documents suggest that although a competitive tender for the state owned monopoly was later announced, British American Tobacco (BAT) and the German manufacturer Reemtsma each initially sought to secure a dosed deal, with BAT accusing Reemtsma of underhand tactics. Imperial Tobacco, which now owns Reemstma, was unable to comment on these allegations as it only acquired Reemstma after the events in question. BAT sought to acquire a monopoly position, bolstered by excise rules developed by the company that would uniquely favour its products. Despite hoping to establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to target young urban dwellers, particularly opinion leaders. In so doing it predicted that smoking uptake would increase, especially among women. The documents also suggest that BAT was aware of the sensitive nature of its plans to cull the processing workforce and aimed to present "sanitised" information on future employment levels to the Moldovans. The potential for tobacco industry privatisation to undermine tobacco control and promote cigarette consumption is highlighted and is consistent with economic theory. Countries planning tobacco industry privatisation should ensure a transparent and competitive privatisation process, seek to prevent the predicted increase in consumption by implementing effective tobacco control policies and consider the impacts on employment. Multilateral financial organisations promoting tobacco industry privatisation. could ensure their loan conditions protect public health by making the implementation of tobacco control policies a pre-requisite for privatisation.
LanguageEnglish
Pages1354-1359
Number of pages6
JournalLancet
Volume365
Issue number9467
StatusPublished - 2005

Fingerprint

Moldova
Tobacco Industry
Privatization
Tobacco
Smoking
Incidence
Jurisprudence
Marketing
Tobacco Products
Industry
Public Health
Economics
Organizations

Cite this

Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova. / Gilmore, A B; Radu-Loghin, C; Zatushevski, I; McKee, M.

In: Lancet, Vol. 365, No. 9467, 2005, p. 1354-1359.

Research output: Contribution to journalArticle

Gilmore, AB, Radu-Loghin, C, Zatushevski, I & McKee, M 2005, 'Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova' Lancet, vol. 365, no. 9467, pp. 1354-1359.
Gilmore AB, Radu-Loghin C, Zatushevski I, McKee M. Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova. Lancet. 2005;365(9467):1354-1359.
Gilmore, A B ; Radu-Loghin, C ; Zatushevski, I ; McKee, M. / Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova. In: Lancet. 2005 ; Vol. 365, No. 9467. pp. 1354-1359
@article{30d332b4724a4d869e870b846384a30f,
title = "Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova",
abstract = "Moldova, one of the former Soviet republics and Europe's poorest country, has so far resisted pressure to privatise its tobacco industry. This paper examines the policies pursued by the transnational tobacco companies in Moldova in order to inform the ongoing debate about tobacco industry privatisation. We analysed relevant internal industry documents made public through litigation. The documents suggest that although a competitive tender for the state owned monopoly was later announced, British American Tobacco (BAT) and the German manufacturer Reemtsma each initially sought to secure a dosed deal, with BAT accusing Reemtsma of underhand tactics. Imperial Tobacco, which now owns Reemstma, was unable to comment on these allegations as it only acquired Reemstma after the events in question. BAT sought to acquire a monopoly position, bolstered by excise rules developed by the company that would uniquely favour its products. Despite hoping to establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to target young urban dwellers, particularly opinion leaders. In so doing it predicted that smoking uptake would increase, especially among women. The documents also suggest that BAT was aware of the sensitive nature of its plans to cull the processing workforce and aimed to present {"}sanitised{"} information on future employment levels to the Moldovans. The potential for tobacco industry privatisation to undermine tobacco control and promote cigarette consumption is highlighted and is consistent with economic theory. Countries planning tobacco industry privatisation should ensure a transparent and competitive privatisation process, seek to prevent the predicted increase in consumption by implementing effective tobacco control policies and consider the impacts on employment. Multilateral financial organisations promoting tobacco industry privatisation. could ensure their loan conditions protect public health by making the implementation of tobacco control policies a pre-requisite for privatisation.",
author = "Gilmore, {A B} and C Radu-Loghin and I Zatushevski and M McKee",
note = "ID number: ISI:000228219600033",
year = "2005",
language = "English",
volume = "365",
pages = "1354--1359",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "9467",

}

TY - JOUR

T1 - Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova

AU - Gilmore,A B

AU - Radu-Loghin,C

AU - Zatushevski,I

AU - McKee,M

N1 - ID number: ISI:000228219600033

PY - 2005

Y1 - 2005

N2 - Moldova, one of the former Soviet republics and Europe's poorest country, has so far resisted pressure to privatise its tobacco industry. This paper examines the policies pursued by the transnational tobacco companies in Moldova in order to inform the ongoing debate about tobacco industry privatisation. We analysed relevant internal industry documents made public through litigation. The documents suggest that although a competitive tender for the state owned monopoly was later announced, British American Tobacco (BAT) and the German manufacturer Reemtsma each initially sought to secure a dosed deal, with BAT accusing Reemtsma of underhand tactics. Imperial Tobacco, which now owns Reemstma, was unable to comment on these allegations as it only acquired Reemstma after the events in question. BAT sought to acquire a monopoly position, bolstered by excise rules developed by the company that would uniquely favour its products. Despite hoping to establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to target young urban dwellers, particularly opinion leaders. In so doing it predicted that smoking uptake would increase, especially among women. The documents also suggest that BAT was aware of the sensitive nature of its plans to cull the processing workforce and aimed to present "sanitised" information on future employment levels to the Moldovans. The potential for tobacco industry privatisation to undermine tobacco control and promote cigarette consumption is highlighted and is consistent with economic theory. Countries planning tobacco industry privatisation should ensure a transparent and competitive privatisation process, seek to prevent the predicted increase in consumption by implementing effective tobacco control policies and consider the impacts on employment. Multilateral financial organisations promoting tobacco industry privatisation. could ensure their loan conditions protect public health by making the implementation of tobacco control policies a pre-requisite for privatisation.

AB - Moldova, one of the former Soviet republics and Europe's poorest country, has so far resisted pressure to privatise its tobacco industry. This paper examines the policies pursued by the transnational tobacco companies in Moldova in order to inform the ongoing debate about tobacco industry privatisation. We analysed relevant internal industry documents made public through litigation. The documents suggest that although a competitive tender for the state owned monopoly was later announced, British American Tobacco (BAT) and the German manufacturer Reemtsma each initially sought to secure a dosed deal, with BAT accusing Reemtsma of underhand tactics. Imperial Tobacco, which now owns Reemstma, was unable to comment on these allegations as it only acquired Reemstma after the events in question. BAT sought to acquire a monopoly position, bolstered by excise rules developed by the company that would uniquely favour its products. Despite hoping to establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to target young urban dwellers, particularly opinion leaders. In so doing it predicted that smoking uptake would increase, especially among women. The documents also suggest that BAT was aware of the sensitive nature of its plans to cull the processing workforce and aimed to present "sanitised" information on future employment levels to the Moldovans. The potential for tobacco industry privatisation to undermine tobacco control and promote cigarette consumption is highlighted and is consistent with economic theory. Countries planning tobacco industry privatisation should ensure a transparent and competitive privatisation process, seek to prevent the predicted increase in consumption by implementing effective tobacco control policies and consider the impacts on employment. Multilateral financial organisations promoting tobacco industry privatisation. could ensure their loan conditions protect public health by making the implementation of tobacco control policies a pre-requisite for privatisation.

M3 - Article

VL - 365

SP - 1354

EP - 1359

JO - Lancet

T2 - Lancet

JF - Lancet

SN - 0140-6736

IS - 9467

ER -